Pioneering Medical Innovations
Explore Incept’s Portfolio, showcasing 25 pioneering companies that have significantly advanced medical technology. From groundbreaking patents to successful exits, our companies exemplify innovation and impact. Discover how our purpose-driven ventures are transforming healthcare and improving lives globally.
Apama Medical – Acquired by Boston Scientific, Inc. (NYSE: BSX) in 2017
Apama Medical was a collaboration between Shifamed and Incept, focused on the development of a novel ablation catheter platform designed to combine the benefits of existing ablation technology, while incorporating additional unique features that address recognized unmet needs in the rapidly growing atrial fibrillation market.
Maya Medical – Acquired by Covidien Ltd. (NYSE: COV) in 2012
Maya Medical started as a collaboration between Shifamed and Incept, focused on the development of a novel percutaneous catheter for treatment of hypertension, a growing market burdened by a staggering proportion of patients who are unable to effectively control their blood pressure.
NextPlane is the leading provider of enterprise-class federation solutions for unified communication (UC) platforms, including Microsoft OCS 2007 R2, OCS 2007 & LCS 2005, IBM Sametime, Cisco Jabber XCP, Cisco WebEx Connect, Cisco Unified Presence Server 8.0, Jive OpenFire, and Google Apps.
Augmenix, Inc. – Acquired by Boston Scientific (NYSE: BSX) in 2016
Augmenix, Inc. was a medical device company that developed and commercialized the SpaceOAR® System, a therapy used to reduce common and debilitating side effects that men may experience after receiving prostate cancer radiotherapy.
Sadra Medical, Inc. – Acquired by Boston Scientific (NYSE: BSX) in 2010
Sadra Medical developed innovative new therapies for the treatment of aortic valve disease, including minimally invasive alternatives to traditional surgical valve replacement—making treatment possible for a broader range of patients.
Acquired in 2007 by Cognizant Technology Solutions Corporation (NASDAQ: CTSH)
MarketRx combined analytics, market research and software services to provide scalable, web-based solutions in three functional areas for Life Sciences companies: Sales Management & Operations, Brand Marketing & Product Management and Market Research.
Kerberos Proximal Solutions is a privately-held medical device company based in Cupertino, Calif. Kerberos is dedicated to developing innovative solutions to treat vascular disease. The Company is focused on delivering their technology and services to interventional cardiologists, interventional radiologists and vascular surgeons.
Nellix, Inc. – Acquired by Endologix Inc. (NASDAQ: ELGX) in 2010
Nellix, Inc., developed novel solutions to address abdominal aortic and other aneurysms within the vascular system using an in situ formed PEG. Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases. Endologix is focusing on the development and marketing of its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA).
Confluent Surgical, Inc. – Acquired by Covidien Ltd. (NYSE: COV) in 2006
Confluent Surgical, Inc. developed and commercialized biomaterials that address intra-operative and post-operative complications, including sealants, adhesion barriers, internal and external adhesives, and hemostatic agents.
EndoTex Interventional Systems, Inc. – Acquired by Boston Scientific, Inc. (NYSE: BSX) in 2007
EndoTex developed a less invasive solution to treating carotid artery disease. The company’s vision was to develop enduring interventional vascular therapeutic solutions that would reduce the need for re-intervention, thereby providing improved quality of life, while reducing the cost of patient care.
